Impact des inhibiteurs de checkpoints immunitaires au cours de la COVID-19 chez les patients atteints de mélanome

por Yatim, N., Boussier, J., Tetu, P., Smith, N., Bruel, T., Corneau, A., Da Meda, L., Allayous, C., Grzelak, L., Staropoli, I., Hadjadj, J., Le Goff, J., Kramkimel, N., Aractingi, S., Blanc, C., Rieux-Laucat, F., Schwartz, O., Terrier, B., Duffy, D., Lebbe, C.
Publicado 2021

Péricardite aiguë et COVID-19

por Dghaies, A., Amri, R., Lajmi, M., Chaabene, I., Garbouj, W., Tounsi, H., Benammou, B., Alaya, Z.
Publicado 2021

Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-contro...

por McCarthy, James S, Yalkinoglu, Özkan, Odedra, Anand, Webster, Rebecca, Oeuvray, Claude, Tappert, Aliona, Bezuidenhout, Deon, Giddins, Marla J, Dhingra, Satish K, Fidock, David A, Marquart, Louise, Webb, Lachlan, Yin, Xiaoyan, Khandelwal, Akash, Bagchus, Wilhelmina M
Publicado 2021

Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic stu...

por Thiruvengadam, Ramachandran, Awasthi, Amit, Medigeshi, Guruprasad, Bhattacharya, Sankar, Mani, Shailendra, Sivasubbu, Sridhar, Shrivastava, Tripti, Samal, Sweety, Rathna Murugesan, Deepika, Koundinya Desiraju, Bapu, Kshetrapal, Pallavi, Pandey, Rajesh, Scaria, Vinod, Kumar Malik, Praveen, Taneja, Juhi, Binayke, Akshay, Vohra, Tarini, Zaheer, Aymaan, Rathore, Deepak, Ahmad Khan, Naseem, Shaman, Heena, Ahmed, Shubbir, Kumar, Rajesh, Deshpande, Suprit, Subramani, Chandru, Wadhwa, Nitya, Gupta, Nimesh, Pandey, Anil K, Bhattacharya, Jayanta, Agrawal, Anurag, Vrati, Sudhanshu, Bhatnagar, Shinjini, Garg, Pramod Kumar
Publicado 2022

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

por Gangneux, Jean-Pierre, Dannaoui, Eric, Fekkar, Arnaud, Luyt, Charles-Edouard, Botterel, Françoise, De Prost, Nicolas, Tadié, Jean-Marc, Reizine, Florian, Houzé, Sandrine, Timsit, Jean-François, Iriart, Xavier, Riu-Poulenc, Béatrice, Sendid, Boualem, Nseir, Saad, Persat, Florence, Wallet, Florent, Le Pape, Patrice, Canet, Emmanuel, Novara, Ana, Manai, Melek, Cateau, Estelle, Thille, Arnaud W, Brun, Sophie, Cohen, Yves, Alanio, Alexandre, Mégarbane, Bruno, Cornet, Muriel, Terzi, Nicolas, Lamhaut, Lionel, Sabourin, Estelle, Desoubeaux, Guillaume, Ehrmann, Stephan, Hennequin, Christophe, Voiriot, Guillaume, Nevez, Gilles, Aubron, Cécile, Letscher-Bru, Valérie, Meziani, Ferhat, Blaize, Marion, Mayaux, Julien, Monsel, Antoine, Boquel, Frédérique, Robert-Gangneux, Florence, Le Tulzo, Yves, Seguin, Philippe, Guegan, Hélène, Autier, Brice, Lesouhaitier, Matthieu, Pelletier, Romain, Belaz, Sorya, Bonnal, Christine, Berry, Antoine, Leroy, Jordan, François, Nadine, Richard, Jean-Christophe, Paulus, Sylvie, Argaud, Laurent, Dupont, Damien, Menotti, Jean, Morio, Florent, Soulié, Marie, Schwebel, Carole, Garnaud, Cécile, Guitard, Juliette, Le Gal, Solène, Quinio, Dorothée, Morcet, Jeff, Laviolle, Bruno, Zahar, Jean-Ralph, Bougnoux, Marie-Elisabeth
Publicado 2022

Acceptation de la vaccination contre la Covid-19 par les patients PR ? Résultats de la cohorte PR Louvain Bruxelles

por Pirson, V., Theunssens, X., Sokolova, T., Curraj, E., Bricman, L., Sapart, E., De Montjoye, S., Dierckx, S., Avramovska, A., Durez, P.
Publicado 2021

Évaluation des patients atteints de polyarthrite rhumatoïde en téléconsultation pendant la première vague de Covid-19

por Avouac, J., Molto, A., Frantz, C., Wanono, S., Descamps, E., Fogel, O., Combier, A., Poiroux, L., Miceli Richard, C., Allanore, Y.
Publicado 2021

Patients PR et Covid-19 : craintes, conséquences et recherche d’information

por Avouac, J., Beller, C., Rollot, S., Pico, I.
Publicado 2021

Étude de l’impact dans la polyarthrite rhumatoïde de la présence de facteur rhumatoïde sur les performances des tests sérologiques pour le Covid-19

por Ferreira-Lopez, R., Tuaillon, E., Pisoni, A., Vincent, T., Reynaud, E., Michel, N., Padern, G., Pers, Y.M., Tisseyre, J., Segura, I., Riera, G., Serre, G., Jorgensen, C.
Publicado 2021

Séroprévalence du SARS-CoV-2 chez 3845 patients atteints de rhumatisme inflammatoire chronique : résultats de la cohorte française COVID-RIC 1

por Pham, T., Ruyssen-Witrand, A., Nogué, E., Molinari, N., Gaujoux-Viala, C., Miceli Richard, C., Fogel, O., Confavreux, C., Mulleman, D., Le Goff, B., Berenbaum, F., Breuil, V., Chary-Valckenaere, I., Devauchelle Pensec, V., Fautrel, B., Flipo, R.M., Richez, C., Tournadre, A., Vittecoq, O., Constantin, A., Balandraud, N., Lafforgue, P., Morel, J.
Publicado 2021

Effet de la vaccination anti-SARS-CoV-2 sur les symptômes prolongés post-Covid : résultat de l’enquête nationale VAXILONG

por Scherlinger, M., Pijnenburg, L., Chatelus, E., Sibilia, J., Gottenberg, J.E., Arnaud, L., Felten, R.
Publicado 2021

Perception de la télémédecine par les consultants en rhumatologie à l’ère de la COVID-19

por Makhlouf, Y., Ben Nessib, D., Haifa, H., Maatallah, K., Ferjani, H., Wafa, T., Kaffel, D., Hamdi, W.
Publicado 2021

L’apparition d’une polyarthrite rhumatoïde post-vaccinale: un effet indésirable potentiel des vaccins à ARNm?

por Alaya, R., Ben Ouhiba, A., Diarra, M., Zalc, J., Nang Nlome Nze, M., Hilliquin, P.
Publicado 2021

Facteurs de risque de réponse insuffisante à la vaccination contre la COVID-19 chez les patients traités par rituximab

por Avouac, J., Miceli Richard, C., Combier, A., Steelandt, A., Fogel, O., Mariaggi, A.A., Méritet, J.F., Rozenberg, F., Molto, A., Allanore, Y.
Publicado 2021

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and old...

por Halperin, Scott A, Ye, Lingyun, MacKinnon-Cameron, Donna, Smith, Bruce, Cahn, Pedro E, Ruiz-Palacios, Guillermo M, Ikram, Aamer, Lanas, Fernando, Lourdes Guerrero, M, Muñoz Navarro, Sergio Raúl, Sued, Omar, Lioznov, Dmitry A, Dzutseva, Vitalina, Parveen, Ghazala, Zhu, Fengcai, Leppan, Laura, Langley, Joanne M, Barreto, Luis, Gou, Jinbo, Zhu, Tao
Publicado 2022

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic

por Rao, Shivani, Yun, Nicole K., Coggan, James L., Wu, Peter, O'Brien, Teresa, Barnett, Katherine, O'Mahony, Sean, Kaur, Ramandeep, Bruti, Christopher, Goetz, Celine, Martin, Jerome J, Gezer, Sefer, Venugopal, Parameswaran, Jain, Shivi
Publicado 2021

Purine Analogues Increase the Risk of Lethal and/or Prolonged COVID19 While Obinutuzumab Increases the Risk of Prolonged but Not Lethal Infection in Patients Treated for Lymphoid M...

por Aurer, Igor, Jaksic, Ozren, Bašić-Kinda, Sandra, Mrdenovic, Stefan, Ostojic Kolonic, Slobodanka, Lozic, Dominik, Holik, Hrvoje, Novakovic Coha, Sabina, Bernes, Petra, Krecak, Ivan, Moric Peric, Martina, Narancic, Marino, Mitrovic, Zdravko, Valkovic, Toni
Publicado 2021

Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy

por Guerra, Veronica A, Ocampo, Marisol, Cusnir, Mike
Publicado 2021

Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination

por Francisco, Michael T., Kaufman, Adrienne E., Northfelt, Donald, Padrnos, Leslie, Rosenthal, Allison C., Andres, Jennifer, Adamski, Jill, Kinard, Theresa, Camoriano, John
Publicado 2021

Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review

por Carrillo, Alessandra, Punatar, Shil, Pavaluri, Sushma, Jentink, Madeline, Patel, Dixita, Braun, Joseph, Todorova, Tsvetelina, Safarpour, Damoun, Farooqui, Marwah W, Ghouse, Masood, Srinivasan, Krishnan
Publicado 2021